Joint hypermobility is characterized by joints that move beyond the normal range of motion. While this can be benign for some, symptomatic joint hypermobility often indicates underlying connective tissue disorders that require medical attention. Conditions such as Ehlers Danlos Syndrome (EDS), Marfan Syndrome, Osteogenesis Imperfecta, and Hypermobility Spectrum Disorder (HSD) share features affecting connective tissues, impacting joints, skin, and internal organs. Key signs suggesting symptomatic joint hypermobility include frequent joint subluxations, dislocations, and sprains. These recurring injuries indicate joint instability, which can lead to chronic pain and early-onset osteoarthritis if untreated. Additionally, gastrointestinal (GI) issues like constipation, nausea, and abdominal pain are common among patients, reflecting how connective tissue disorders can affect the digestive system. Neurological symptoms such as clumsiness and poor balance further demonstrate the systemic nature of these conditions. Fatigue is a pervasive concern, often linked to the body's increased effort to stabilize loose joints and maintain posture. Autonomic dysfunction—which can manifest as irregular heart rate, blood pressure anomalies, and dizziness—is frequently reported, emphasizing the need for a multidisciplinary approach to care. Other notable manifestations include bladder problems and stretchy skin, both signs of connective tissue fragility. Recognizing these symptoms early can lead to proper diagnosis and management, improving quality of life through physical therapy, pain management, and lifestyle modifications. If you experience multiple symptoms from these categories, consulting a specialist familiar with connective tissue disorders is essential. Genetic testing and clinical evaluations help confirm diagnoses like EDS or Marfan Syndrome. Early intervention can mitigate complications, support joint function, and address systemic symptoms effectively.